Embryologist 1
eGenesis
Embryologist 1
eGenesis
Genetically engineered porcine kidneys for humans
The Embryologist I provides critical embryology support for GMP production within the GMP production facility. This position reports to the Associate Director of GMP Production. The Embryologist will operate in strict accordance with company Standard Operating Procedures (SOPs), GMP facility protocols, and regulatory agency guidelines to advance the company’s core mission. This position requires adherence to strict biosecurity protocols, including showering-in to the animal facility to perform designated tasks.
While performing the duties of this job, the employee is regularly required to work in different environments, including farm, shop, office, and animal husbandry environments in varying weather conditions. The employee frequently is required to be walking, stooping, climbing, and crouching. Employees are regularly expected to lift objects 30-60lbs multiple times throughout the day. Specific vision abilities required by this job include close vision, distance vision, color vision, peripheral vision, depth perception and ability to adjust to focus.
This job operates in multiple environments, including office, laboratory, surgery, necropsy, and animal husbandry environment. This role routinely uses standard office equipment such as computers, phones, copy machines, filing cabinets, and fax machines. This job may require the use of hazardous chemicals, conduct sample collection on livestock and operate in a dusty environment.
#IH
eGenesis develops genetically engineered porcine (pig) kidneys and other organs that are compatible with human bodies, aiming to address the organ shortage by enabling transplantations into humans. Its product is created by editing pig genes to reduce rejection and improve compatibility, producing HuCo™ (Human Compatible) organs and cells that can be transplanted by healthcare providers. Unlike many biotech firms that focus on synthetic tissues or other approaches, eGenesis concentrates on xenotransplantation—using animal organs engineered to be accepted by the human immune system—for use in patients awaiting transplants. The company’s goal is to save lives and improve quality of life by expanding the supply of transplantable organs and reducing wait times for patients in need.
Explore more opportunities at eGenesis